POLYMUN Scientifc Immunbiologische Forschung GmbH
About POLYMUN Scientifc Immunbiologische Forschung
Polymun was founded in 1992 by Prof. Hermann Katinger.Revenues are generated by contract development and manufacturing of biopharmaceuticals and liposomal formulations of drugs. Revenues are invested in the proprietary product pipeline and the further development of technology platforms. The R&D projects and technologies are open for co-development and licensing. Polymun operates in accordance with current GMP guidelines and holds an Austrian production license for pharmaceuticals (§63 Austrian Pharmaceutical Law) thus meeting the EU requirements for drug manufacturing.
- Focus : Manufacturer
- Industry : Biotechnology